Proving the Business Case for the Internet of Things

GSK, Medidata look to mobile technology for clinical care improvements

Iain Morris
November 19, 2014

Pharmaceuticals giant GlaxoSmithKline (GSK) has teamed up with cloud player Medidata to investigate how mobile health technology could improve clinical care.

The companies have been working together at GSK’s facilities on using mobile health technologies to collect large volumes of data that can provide insight into the wellbeing of patients.

So far, they claim the studies have shown that mobile devices can help to streamline routine procedures, eliminate unnecessary ones and reduce visits to clinical trial sites.

“Working with GSK on this initiative has provided us with an exciting opportunity to show how technology can be used to enhance patient engagement and accelerate the pace of innovation in drug development,” said Glen de Vries, Medidata’s president.

“We gathered data on an unprecedented scale – collecting more than 18 million data points on activity and vital signs per participant per day,” he added. “This is an extraordinary level of in-life, real-time patient instrumentation for clinical trials, which will create new disciplines and new opportunities for life science companies.”

During the trials carried out so far, Medidata (New York City, NY, USA) and GSK (Brentford, UK) provided program participants with two wearable devices – Vital Connect’s (Campbell, CA, USA) HealthPatch MD and ActiGraph’s (Pensacola, FL, USA) wGT3X-BT Monitor – allowing them to continuously monitor vital signs, electrocardiogram data and activity levels.

Participants also made use of Medidata Patient Cloud, a mobile app for patient-reported outcomes that forms a part of Medidata’s industry-leading technology platform.

Smartphones used by the patients were able to capture data from the mobile health devices, pull this into the Medidata cloud and then map it to clinical records.

During the trails, participants were asked to go about their standard daily routines and check in with the performance lab only at the start and end of the effort.

“Seamlessly integrating data from HealthPatch MD into clinical records through the Medidata Clinical Cloud opens up new possibilities to measure biometrics, from heart rate to skin temperature,” said Nersi Nazari, Vital Connect’s chairman and chief executive officer.

“The availability of continuous, clinical-grade health data provides important opportunities to analyze results in real time to quickly identify potential safety concerns and adjust a trial based on preliminary evidence,” added Nazari.

Medidata says its data science team is working with GSK to leverage the project data and turn it into “actionable insight” that can be used to conduct faster and more patient-centric clinical research.

“When it comes to mHealth, there is one aspect everyone agrees on: the technology is here now,” said de Vries. “Breakthroughs in mHealth adoption can come from clear demonstrations of using mobile devices in a compliant, effective and safe way.”

“We believe these breakthroughs over time will help to alleviate any concerns about regulatory compliance and data quality, much like the early days of the Internet and electronic data capture,” he added.
 
 
Other News
 
GTX's Goal: Empower a New Era of Personal Location Services and Wearable Technology
 
GTX Corp provides wearable technology incorporating miniaturised devices for tracking people and valuables.  
Read Full Story>>
 
Wireless Mesh Technology Used in Life Saving Application

Low power consumption and low cost of the Zigbee modules have provided an alternative to wired systems, also the ease of retrofitting in buildings where running cables would be disruptive and time consuming.
Read Full Story>>